Pharma's Almanac | IBio, Inc.

17 Articles Available

Oncology

Changing the Paradigm of Cancer Drug Discovery and Development with Plants

PAO-02-022-CL-02

mAbs

Quality Plant-Made mAbs with FastPharming®

COVID-19 Vaccine

iBio Reports Successful COVID-19 Vaccine Toxicology Study Results and Announces Next-Gen COVID-19 Vaccine Program

PR-M05-21-005

COVID-19 Vaccine

Applying Rapid Countermeasure Preparedness to Development of a Novel COVID-19 Vaccine

PAO-M04-20-CL-002

Vaccine

iBio Expands COVID-19 Vaccine Collaboration to Include the Infectious Disease Research Institute

PR-M04-20-NI-015

Biosimilar

iBio Supporting AzarGen Biotechnologies’ Development of a Rituximab Biosimilar

PR-M04-20-NI-014

COVID-19 Vaccine

iBio Announces Advancement of COVID-19 Vaccine Program

PR-M04-20-NI-013

Biosecurity

iBio Joins the Alliance for Biosecurity

PR-M03-20-NI-038

COVID-19 Vaccine

iBio Announces Development of Proprietary COVID-19 Vaccine Candidates

PR-M03-20-NI-037

3D Bioprinting

Facilitating 3D Organ Printing with Plant-Based BioInks

PAP-Q4-19-CL-018

Collaboration

iBio’s Collaboration with South Africa’s AzarGen Biotechnologies Advances to Next Stage

PR-M09-19-NI-048

Collaboration

iBio and CC-Pharming Expand Business Collaboration in China

PR-M08-19-NI-087

Speed to Market

FastPharming for Speed to Market

PTV-M08-19-BIO-008

Fill-Finish

Reducing Fill-Finish Wait Times

PAO-NI-0719-CL-003

Fill/Finish Agreement

iBio Announces First Agreement for Fill-Finish Services

PR-M06-19-NI-033

Plant-Based Innovation

The Advantage of Plant-Based Expression Solutions Around the Globe

PAO-M05-19-CL-002

Plant-Based Solutions

Plant-based Protein Expression for Rapid, Green Bioprocessing

PAP-Q2-2019-CL-022

IBio, Inc.

17 Articles Available

Can't find what you're looking for? Try our advanced search.

Oncology

Changing the Paradigm of Cancer Drug Discovery and Development with Plants

mAbs

Quality Plant-Made mAbs with FastPharming®

COVID-19 Vaccine

iBio Reports Successful COVID-19 Vaccine Toxicology Study Results and Announces Next-Gen COVID-19 Vaccine Program

COVID-19 Vaccine

Applying Rapid Countermeasure Preparedness to Development of a Novel COVID-19 Vaccine

Vaccine

iBio Expands COVID-19 Vaccine Collaboration to Include the Infectious Disease Research Institute

Biosimilar

iBio Supporting AzarGen Biotechnologies’ Development of a Rituximab Biosimilar

COVID-19 Vaccine

iBio Announces Advancement of COVID-19 Vaccine Program

Biosecurity

iBio Joins the Alliance for Biosecurity

COVID-19 Vaccine

iBio Announces Development of Proprietary COVID-19 Vaccine Candidates

3D Bioprinting

Facilitating 3D Organ Printing with Plant-Based BioInks

Collaboration

iBio’s Collaboration with South Africa’s AzarGen Biotechnologies Advances to Next Stage

Collaboration

iBio and CC-Pharming Expand Business Collaboration in China

Speed to Market

FastPharming for Speed to Market

Fill-Finish

Reducing Fill-Finish Wait Times

Fill/Finish Agreement

iBio Announces First Agreement for Fill-Finish Services

Plant-Based Innovation

The Advantage of Plant-Based Expression Solutions Around the Globe

Plant-Based Solutions

Plant-based Protein Expression for Rapid, Green Bioprocessing